36
Participants
Start Date
June 30, 2000
Primary Completion Date
September 30, 2002
Study Completion Date
January 31, 2006
dexamethasone
semaxanib
Veterans Affairs Medical Center - Durham, Durham
Michiana Hematology/Oncology P.C., South Bend
Oncology Care Associates, P.L.L.C., Saint Joseph
Division of Hematology/Oncology, Park Ridge
Loyola University Medical Center, Maywood
Evanston Northwestern Health Care, Evanston
Ingalls Memorial Hospital, Harvey
LaGrange Memorial Hospital, LaGrange
University of Illinois at Chicago, Chicago
Louis A. Weiss Memorial Hospital, Chicago
Oncology/Hematology Associates of Central Illinois, P.C., Peoria
Cancer Care Specialists of Central Illinois, S.C., Decatur
Central Illinois Hematology Oncology Center, Springfield
City of Hope Medical Group, Pasadena
Cancer Center and Beckman Research Institute, City of Hope, Duarte
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles
University of Chicago Cancer Research Center, Chicago
Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne
National Cancer Institute (NCI)
NIH
University of Chicago
OTHER